TORS as a Primary Treatment Modality in the Treatment of HPV-Related Oral Pharynx Cancers

Otolaryngologist Carole Fakhry, M.D., discusses the use of transoral robotic surgery (TORS) in the treatment of HPV-related oral pharynx cancer, and how its use can de-intensify and reduce morbidities from typically used adjuvant treatment therapies.


Created by

Johns Hopkins Medicine

Related Presenters

Carole Fakhry, MD, MPH

Carole Fakhry, MD, MPH

Associate Professor of Otolaryngology - Head and Neck Surgery

Expertise: Cancer of Unknown Primary, Head and Neck Cancers, Human Papillomavirus Infections, Hyperparathyroidism, Laryngeal Cancer, Neck Masses, Oropharynx Cancers, Otolaryngology, Parathyroid Diseases, Parathyroid Surgery, Pharynx Cancer, ...

View full profile